Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

4.72
Delayed Data
As of May 26
 -0.35 / -6.90%
Today’s Change
1.51
Today|||52-Week Range
6.21
+131.37%
Year-to-Date

Today’s Trading

Previous close5.07
Today’s open5.05
Day’s range4.56 - 5.06
Volume2,413,289
Average volume (3 months)2,060,312
Market cap$453.0M
Dividend yield--
Data as of 4:14pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-135.21%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-29.86%
P/E ratioNM
Price/Sales4.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GERNGeron Corp-0.24-7.97%
BCRXBioCryst Pharmaceuti...-0.96-14.26%
BOLDAudentes Therapeutic...-0.41-2.61%
NTLAIntellia Therapeutic...-0.33-2.43%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$60.0M
Annual profit (last year)-$144.8M
Net profit margin-241.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts